Login

The Opening Bell marks 25 years of Encavis AG being listed on the stock exchange. 00:10:00

Share On Facebook Share On Twitter

The Chief Executive Officer (CEO) of Encavis AG, Dr Dierk Paskert (61)

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Attracting Long-Term Institutional Capital in Junior Mining: Key Strategies
00:10:00
Zobel expressed confidence in the company's future, as stated by Manila Water President and CEO Jose Rene Gregory D. Almendras.
00:00:00
William A. Faubion, M.D.
00:00:00
Mabel Ryder, M.D. Endocrinologist, Mayo Clinic
00:00:00
Jesper Söderqvist, CEO, Boule Diagnostics
00:10:00
Cogeco Communications Inc. and Cogeco Inc., led by CEO Louis Audet, are telecommunications and media companies listed on the Toronto Stock Exchange|Frederic Perron its new president and CEO of Cogeco Communications Inc.
00:00:00
Ian Walters, CEO, SalvaRx Group Plc
00:10:00
we have partnered with startups in sectors ranging from e-commerce to Government technology|Alex Rubalcava,Managing Partner,Stage Venture Partners
00:10:00
Biocept's Liquid Biopsy Innovations: CEO Mike Nall Discusses 2019 Achievements and 2020 Outlook
00:10:00
Ken Armstrong Discusses North Arrow Minerals' Strategic Shift Towards Lithium Exploration in Canada
00:10:00
Thesis Gold and Benchmark Metals: A Transformative Merger for Precious Metals Development
00:10:00
Greg Foran at IATA AGM 2022: Insights from Air New Zealand’s CEO | Greg Foran, CEO, Air New Zealand Ltd .

© 2017 - Neuhu+